至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Design of a synthetic miniR1 plasmid and its production by engineered Escherichia coli

Bioprocess Biosyst Eng. 2019-08; 
Lara AR, Velázquez D, Penella I, Islas F, González-De la Rosa CH, Sigala JC
Products/Services Used Details Operation
Plasmid DNA Preparation The sequences of all parts used are given in Table 1. The construct was flanked by HindIII and BamHI restriction sites and synthesized by a specialized company (GenScript, NJ, USA) … pUC57Kan plasmid (2579 bp) was purchased from GenScript (NJ, USA) … The sequences of all parts used are given in Table 1. The construct was flanked by HindIII and BamHI restriction sites and synthesized by a specialized company (GenScript, NJ, USA) … pUC57Kan plasmid (2579 bp) was purchased from Gen- Script (NJ, USA) … Get A Quote

摘要

A synthetic plasmid consisting of the minimal elements for replication control of the R1 replicon and kanamycin resistance marker, which was named pminiR1, was developed. pminiR1 production was tested at 30 °C under aerobic and microaerobic conditions in Escherichia coli W3110 recA- (W1). The plasmid DNA yields from biomass (YpDNA/X) were only 0.06 ± 0.02 and 0.22 ± 0.11 mg/g under aerobic and microaerobic conditions, respectively. As an option to increase YpDNA/X values, pminiR1 was introduced in an engineered E. coli strain expressing the Vitreoscilla hemoglobin inserted in chromosome (W12). The YpDNA/X values using strain W12 increased to 0.85 ± 0.05 and 1.53 ± 0.14 mg/g under aerobic an... More

关键词

Microaerobic; Minimal plasmid; R1 replicon; Synthetic plasmid; Vitreoscilla hemoglobin